CBRE CEO reports 40,636-share equity award grant

CBRE Group Chair & CEO Robert E. Sulentic reported an equity award and related tax share disposition.

Rhea-AI Filing Summary

CBRE Group Chair & CEO Robert E. Sulentic reported an equity award and related tax share disposition. He acquired 40,636 shares of Class A Common Stock on February 25, 2026 as a 2026 annual equity award at no cash cost. According to the award terms, these shares vest 25% each year on February 25, 2027, 2028, 2029 and 2030, subject to possible forfeiture or acceleration under the award agreement. On the same date, 3,426 shares were disposed of at $147.24 per share to satisfy tax withholding, a non‑open‑market transaction. After these transactions, he directly owned 1,385,958 shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider SULENTIC ROBERT E

Role Chair & CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	40,636	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock	3,426	$147.24	$504K

Holdings After Transaction: Class A Common Stock — 1,385,958 shares (Direct)

Footnotes (1)

1. F1. The Issuer granted these securities to the Reporting Person on February 25, 2026 as part of the Reporting Person's 2026 annual equity award. These securities will vest at a rate of 25% per year on each of February 25, 2027, 2028, 2029 and 2030, subject to forfeiture or acceleration in certain circumstances as set forth in the award agreement for these securities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CBRE (CBRE) CEO Robert Sulentic report in this Form 4?

Robert E. Sulentic reported an annual equity award and a related tax withholding share disposition. He received 40,636 CBRE Class A shares as a 2026 equity grant and used 3,426 shares to cover tax obligations, all reported as direct ownership changes.

How many CBRE shares were granted to the CEO in this filing?

The CEO was granted 40,636 shares of CBRE Class A Common Stock. This grant is part of his 2026 annual equity award and was recorded at zero price per share, reflecting a compensation award rather than an open‑market purchase transaction.

What are the vesting terms of Robert Sulentic’s 2026 CBRE equity award?

The 40,636 awarded shares vest in four equal annual installments of 25%. Vesting dates are February 25, 2027, 2028, 2029 and 2030, and the award is subject to forfeiture or acceleration under conditions described in the applicable award agreement.

Why were 3,426 CBRE shares disposed of in this Form 4?

The 3,426 shares were disposed of to satisfy tax withholding obligations tied to the equity award. They were valued at $147.24 per share and classified as a tax‑withholding disposition, not an open‑market sale for portfolio or liquidity purposes.

How many CBRE shares does the CEO own after these transactions?

After the award and tax‑withholding disposition, Robert E. Sulentic directly owns 1,385,958 CBRE Class A shares. This figure reflects his updated direct beneficial ownership following both the grant acquisition and the related share disposition on February 25, 2026.

Was the CBRE CEO’s share acquisition in this filing a market purchase?

No, the acquisition reflects an equity compensation grant, not a market purchase. The 40,636 shares were issued at zero price as part of his 2026 annual equity award, with vesting over four years rather than being bought on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 06:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SULENTIC ROBERT E

(Last) (First) (Middle)

2121 NORTH PEARL STREET

SUITE 300

(Street)

DALLAS TX 75201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CBRE GROUP, INC. [ CBRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/25/2026		A(1)		40,636	A	$0.0000	1,389,384	D
Class A Common Stock	02/25/2026		F		3,426	D	$147.24	1,385,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Issuer granted these securities to the Reporting Person on February 25, 2026 as part of the Reporting Person's 2026 annual equity award. These securities will vest at a rate of 25% per year on each of February 25, 2027, 2028, 2029 and 2030, subject to forfeiture or acceleration in certain circumstances as set forth in the award agreement for these securities.

	/s/ Andria Iles, Attorney-in-Fact for Robert E. Sulentic	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.